Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Stefan KommossAndreas D HartkopfBernhard KrämerAnne-Kathrin BunzFriederike GrevenkampFelix KommossJana PasternakSabine M ArbabiMarkus WallwienerAnnette StaeblerSigurd F LaxSara Y BruckerFlorin-Andrei Taran

Published in: Journal of cancer research and clinical oncology (2017)

We were able to confirm previous findings of DTC presence in a large well-characterized cohort of endometrial carcinoma patients. DTC are detectable in almost one-fifth of endometrial carcinoma and occur less frequently with a MELF pattern of invasion. Further studies investigating the role of DTC in endometrial carcinoma are warranted.

Keyphrases

endometrial cancer
risk factors
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
case control